Global Cord Blood Corporation CO
Set alert
2.99 +2.99 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 400.08M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 5.15
- Beta
- -0.04
- Short ratio
- 0.00
- Inst. own
- 22.17%
- Dividend
- 0.00
- Ex-div date
- Jul 30, 2018
- Earnings
- Jul 4, 2023
- 50-d avg
- 2.69
- 200-d avg
- 2.89
- 1y target
- 0.00
Key statistics
- Market cap
- 400.08M
- Enterprise value
- -6.26B
- Trailing P/E
- 5.06
- Forward P/E
- 5.15
- PEG ratio
- 0.00
- Price / sales
- 0.32
- Price / book
- 0.07
- EPS (TTM)
- 0.59
- Beta
- -0.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 40.30%
- Revenue (TTM)
- 1.24B
- Revenue growth
- -1.70%
- Free cash flow
- 378.58M
- Total cash
- 6.66B
- Total debt
- 147.00K
- Return on equity
- 10.99%
- Shares outstanding
- 133.91M
- Short % of float
- 2.08%
- 50-day average
- 2.69
- 200-day average
- 2.89
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Jul 4, 2023
Expected Jul 4, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jul 4, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Jan 4, 2023 | Sep 1, 2022 | 0.00 | — | — | — |
| Jul 5, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Feb 28, 2022 | Dec 1, 2021 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 5, 2016 | Scotia Howard Weil | down | Outperform | Sector Perform |
| Aug 7, 2015 | Jefferies | main | — | Buy |
| Jun 26, 2015 | Roth Capital | down | Buy | Neutral |
| Mar 18, 2015 | Jefferies | main | — | Buy |
| Dec 12, 2012 | Aegis Capital | init | — | Buy |
About Global Cord Blood Corporation
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- Hong Kong
- Website
- globalcordbloodcorp.com
News
- New First Alert® Smoke and Carbon Monoxide Alarms Make Home Safety Simple
- Is Winter About to Show Off? Vail Resorts Announces 2026/27 Opening Dates as Super El Niño Builds Anticipation for Great Powder
- Kidde Enhances Carbon Monoxide (CO) Detection with Advanced Low-Level Alarms
- Global Cord Blood (NYSE:CO) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened
- Real Yields, Oil, Conflict Scenarios
- CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF
- CO, CORBF Deadline: CO, CORBF Investors Have the Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit
- INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord
- ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF
- ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF
Your note
Sign in to keep a note on CO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JAYHAWK PRIVATE EQUITY FUND II L P | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 13, 2015 | 0 |
| MCCARTHY KENT C | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 1, 2015 | 0 |
| VICTORY PARK CAPITAL ADVISORS L L C | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 29, 2009 | 0 |
| YA GLOBAL INVESTMENTS L P | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 29, 2009 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Oasis Management Co Ltd. | 5.59% | 6,797,574 | 20.31M | Mar 30, 2023 |
| Renaissance Technologies, LLC | 1.93% | 2,348,549 | 7.02M | Mar 30, 2023 |
| Man Group PLC | 1.48% | 1,801,336 | 5.38M | Mar 30, 2023 |
| BlueCrest Capital Management Ltd | 0.62% | 748,889 | 2.24M | Mar 30, 2023 |
| Quinn Opportunity Partners, LLC | 0.27% | 324,494 | 969.46K | Mar 30, 2023 |
| Iszo Capital Management LP | 0.23% | 279,495 | 835.02K | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Parametric International Equity Fund | 0.02% | 29,600 | 88.43K | Jan 30, 2023 |
| Avantis Emerging Markets Equity ETF | 0.02% | 18,571 | 55.48K | Mar 30, 2023 |
| Northern Small Cap Core Fund | 0.01% | 6,346 | 18.96K | Mar 30, 2023 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 0.01% | 8,412 | 25.13K | Mar 30, 2023 |
| Avantis Emerging Markets Equity Fund | 0.00% | 2,020 | 6.03K | Feb 27, 2023 |